Abstract:Purpose Itraconazole (ITZ) is a synthetic triazole antifungal agent, which is widely used for treatment and prevention of fungal infections. The purpose of this study is to develop ITZ-loaded poly(lactic-co-glycolic acid) (PLGA) nanospheres (PLGA-ITZ-NS) as a new sustained-release formulation for intravenous ITZ administration. Materials and methods PLGA-ITZ-NS were prepared by a nanoprecipitation method and optimized by modifying the surfactant poloxamer 188 concentration and PLGA:ITZ ratio. Their physicochemical properties, including size, zeta potential, external morphology and encapsulation efficiency, were characterized by dynamic light scattering (DLS), scanning electron microscopy (SEM) and high performance liquid chromatography (HPLC). The effect of the different selected lyoprotectants with various concentrations on NS particles size and surface charge were also assessed. Rapid and sensitive HPLC and liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed to determine ITZ concentrations in formulation and in rat plasma, respectively. Pharmacokinetics of the optimum PLGA-ITZ-NS formulation was compared with the former commercial Sporanox® injection formulation using rats as the animal model. Noncompartmental pharmacokinetic parameters were obtained by WinNonlin® software. Results Optimal PLGA-ITZ-NS had a mean particle size of about 200 nm with a high homogeneity (polydispersity index ≈0.2), favorable zeta potential (approximately −20 to −30 mV) and encapsulation efficiency (72%). In addition, 2% w/v sucrose was selected as a lyoprotectant for NS freeze-drying. The newly developed LC-MS/MS assay was validated and found to be accurate and precise. The in vivo study showed that the NS formulation has a similar systemic bioavailability to Sporanox® while providing a sustained plasma level (> 100 ng/mL) for up to 24 hours after intravenous administration. Conclusion Our newly developed PLGA-ITZ-NS has shown great sustained release and comparable bioavailability with Sporanox®, therefore having the potential to be an alternative injectable formulation of ITZ.

Preparation and Characterization of Itraconazole Albumin Nanosuspensions

Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation

Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.

Study on Preparation of Itraconazole Solid Lipid Nanoparticles

Formulation and Characterization of Biocompatible and Stable I.V. Itraconazole Nanosuspensions Stabilized by a New Stabilizer Polyethylene Glycol-Poly(β-benzyl- L -Aspartate) (PEG-PBLA)

Studies on the Preparation and Properties of the Itraconazole Inclusion Complexes Injection

Orthogonal Experiments Optimizes the Formulations and Preparation Conditions of Itraconazole Solid Lipid Nanoparticles

Preparation of Itraconazole Amorphous Solid Dispersion and Preliminary Evaluation in Vitro

Preparation of Itraconazole Nanoparticles by Anti-Solvent Precipitation Method Using a Cascaded Microfluidic Device and an Ultrasonic Spray Drier

Preparation of Itraconazole Solid Dispersion with PVP and Dissolution Experiment in Vitro

The Increased Dissolution and Oral Absorption of Itraconazole by Nanocrystals with an Endogenous Small-Molecule Surfactant as a Stabilizer

Development of PLGA-based itraconazole injectable nanospheres for sustained release

Formulation and Evaluation of Lipid-based Nanoformulation of Itraconazole

Preparation and physico-chemical properties of itraconazole polymeric micelles using mPEG-PLA as a drug carrier

Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.

Formulation and Characterization of Immediate-Release Itraconazole-Loaded Pellets Prepared by Fluidized Bed Spray Coating

Potent Dried Drug Nanosuspensions for Oral Bioavailability Enhancement of Poorly Soluble Drugs with Ph-Dependent Solubility

Continuous Preparation of Itraconazole Nanoparticles Using Droplet-Based Microreactor

Study on Pharmacokinetics of Itraconazole Intramuscular Injection

Development of an itraconazole encapsulated polymeric nanoparticle platform for effective antifungal therapy

Preparation and the release characteristic in vitro of arsenic trioxide albumin nanospheres